Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 45 years of age or older
- You have been diagnosed with Type 2 diabetes based on standard medical guidelines
- You are willing and able to complete a series of memory and thinking tests
- You understand what the study involves, including possible benefits and risks, and are willing to sign a consent form
Who may not be able to join:
- You have had fewer than 6 years of formal education
- You are left-handed
- You have been diagnosed with dementia
- You have had a serious diabetes-related emergency (such as diabetic ketoacidosis, dangerously high blood sugar, or a coma caused by low blood sugar) in the past 3 months
- You have a history of, or currently have, any neurological (brain or nerve) or psychiatric (mental health) condition
- You currently have an underactive thyroid (hypothyroidism)
- You have a history of cancer, or have severe kidney or liver problems
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yan Bi, M.D., Ph.D., Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Phone: (86) 25-83105313
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence, incidence of cognitive dysfunction in type 2 diabetes; Risk factors for cognitive dysfunction in type 2 diabetes, such as diabetes duration, poor glycemic control, hypertension, obesity, dyslipidemia, and active inflammation, et al.; Biomarkers of cognitive dysfunction in type 2 diabetes; Glycemic control targets for cognitive dysfunction in type 2 diabetes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.